World

Biotech to test new therapy for stroke – Boston Herald



By Kris B. Mamula, Pittsburgh Post-Gazette

A 3-year-old Sewickley, Pennsylvania, biotech firm is partnering with a Boston hospital to test a new drug combination, which has the promise of helping people debilitated by stroke.

Neuro-Innovators LLC is collaborating with Spaulding Rehabilitation Hospital to evaluate the effectiveness of Neuro-Innovators’ NIV-001 therapy to enhance and restore mobility and function lost through a burst or blocked vessel in the brain, which causes stroke. Some 750,000 people suffer strokes each year in the U.S. and two-thirds of more than seven million stroke survivors are left disabled, according to the Stroke Awareness Foundation, a Campbell, California-based nonprofit.



Source link

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *